| Name | Title | Type |
|---|---|---|
| Jay Katz | Executive Director | Auditee |
| Patricia McGowan | Partner | Auditee |
| Jonathan Fink | Principal | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 362935 | 2024 | 2025-07-24 | Cliftonlarsonallen LLP | $1.74M |
| 303527 | 2023 | 2024-04-15 | Cliftonlarsonallen LLP | $1.65M |
| 34988 | 2022 | 2023-01-16 | Cohnreznick LLP | $1.65M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 362935 | 2024 | 2025-07-24 | 1148341 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 1148340 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 1148339 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 1148338 | 2024-001 | Significant Deficiency | Yes | C |
| 362935 | 2024 | 2025-07-24 | 1148337 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 1148336 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 1148335 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 1148334 | 2024-001 | Significant Deficiency | Yes | C |
| 362935 | 2024 | 2025-07-24 | 571899 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 571898 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 571897 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 571896 | 2024-001 | Significant Deficiency | Yes | C |
| 362935 | 2024 | 2025-07-24 | 571895 | 2024-004 | Significant Deficiency | Yes | A |
| 362935 | 2024 | 2025-07-24 | 571894 | 2024-003 | Significant Deficiency | - | C |
| 362935 | 2024 | 2025-07-24 | 571893 | 2024-002 | Significant Deficiency | - | A |
| 362935 | 2024 | 2025-07-24 | 571892 | 2024-001 | Significant Deficiency | Yes | C |
| 303527 | 2023 | 2024-04-15 | 969701 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 969700 | 2023-001 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 969699 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 969698 | 2023-001 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393259 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393258 | 2023-001 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393257 | 2023-002 | Significant Deficiency | - | N |
| 303527 | 2023 | 2024-04-15 | 393256 | 2023-001 | Significant Deficiency | - | N |